Your session is about to expire
← Back to Search
Ibuprofen, acetaminophen, oxycodone for Cesarean Section Complications (ERAS Trial)
ERAS Trial Summary
This trial will test whether or not scheduled medications can reduce the risk of persistent opioid use for women after cesarean delivery.
ERAS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ERAS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current enrollment size for this clinical trial?
"Affirmative. Clinicaltrials.gov's data confirms that this medical experiment, which was initially posted on December 12th 2020, is presently recruiting patients. Approximately 120 individuals must be enrolled from one trial site."
Does this research study allow for participants who are older than 50?
"To be considered for this clinical trial, patients must fall between the ages of 18 and 50."
Is this investigation still recruiting participants?
"According to the clinicaltrials.gov database, this trial is currently in search of participants. It was initially unveiled on December 12th 2020 and amended as recently as May 17th 2022."
Are there any chronicles of prior experiments examining the effectiveness of ibuprofen, acetaminophen, and oxycodone?
"Currently, 122 medical studies are currently exploring the effects of Ibuprofen, acetaminophen, oxycodone. Of these trials, 35 have progressed to Phase 3 and more than a thousand locations worldwide are running experiments for this medication. The concentration of research is particularly high in Pittsburgh Pennsylvania."
Could I potentially be a participant in this experiment?
"Successful applicants to this medical study must have undergone a cesarean section, and be between 18-50 years of age. The desired total enrolment is 120 individuals."
To what ailments are Ibuprofen, acetaminophen, and oxycodone typically prescribed?
"Ibuprofen, acetaminophen, and oxycodone are frequently prescribed to manage catarrh. These medications can also be employed for rhinorrhoea, musculoskeletal pain relief, and muscle spasms treatment."
What primary goals are this clinical trial aiming to achieve?
"The principle gauge of this trial's success is the amount of morphine milligram equivalents used from 25-72 hours post-operation. Additionally, researchers will also observe patients' ambulation on outpatient day #1-3 by recording their steps with a fitness tracker, measure their satisfaction levels with pain management upon discharge using a line scale in centimeters, and assess perceived readiness to return home through an administered questionnaire."
Share this study with friends
Copy Link
Messenger